摘要
Owing to the complex and often asymptomatic presentations,the diagnosis of biliopancreatic diseases,including pancreatic and biliary malignancies,remains challenging.Recent technological advancements have remarkably improved the diagnostic accuracy and patient outcomes in these diseases.This review explores key advancements in diagnostic modalities,including biomarkers,imaging techniques,and artificial intelligence(AI)-based technologies.Biomarkers,such as cancer antigen 19-9,KRAS mutations,and inflammatory markers,provide crucial insights into disease progression and treatment responses.Advanced imaging modalities include enhanced computed tomography(CT),positron emission tomography-CT,magnetic resonance cholangiopancreatography,and endoscopic ultrasound.AI integration in imaging and pathology has enhanced diagnostic precision through deep learning algorithms that analyze medical images,automate routine diagnostic tasks,and provide predictive analytics for personalized treatment strategies.The applications of these technologies are diverse,ranging from early cancer detection to therapeutic guidance and real-time imaging.Biomarker-based liquid biopsies and AI-assisted imaging tools are essential for non-invasive diagnostics and individualized patient management.Furthermore,AI-driven models are transforming disease stratification,thus enhancing risk assessment and decision-making.Future studies should explore standardizing biomarker validation,improving AI-driven diagnostics,and expanding the accessibility of advanced imaging technologies in resource-limited settings.The continued development of non-invasive diagnostic techniques and precision medicine approaches is crucial for optimizing the detection and management of biliopancreatic diseases.Collaborative efforts between clinicians,researchers,and industry stakeholders will be pivotal in applying these advancements in clinical practice.
